← to majors
Broadwood Capital Inc
asset manager · portfolio $1.91 B · 6 positions · report for 30.06.2026
Stock positions report for 30.06.2026, filed 14.08.2026; change — vs 31.03.2026 · 6
| Company | Shares | Value | % of portfolio | Quarter change |
|---|---|---|---|---|
| Monster Beverage Corp US:MNST | 8 107 796 | $779 M | 40.73% | — |
| STAAR Surgical Company US:STAA | 16 123 842 | $463 M | 24.18% | — |
| Axon Enterprise Inc. US:AXON | 693 504 | $389 M | 20.32% | — |
| iShares Russell 2000 ETF US:IWM · ETF | 474 920 | $143 M | 7.46% | — |
| Insight Molecular Diagnostic… US:IMDX | 12 684 884 | $74.8 M | 3.91% | +753 045 |
| Lineage Cell Therapeutics In… US:LCTX | 49 560 992 | $64.9 M | 3.39% | — |
In companies of our database 3
| Company | Stake | Shares | Report date |
|---|---|---|---|
| Insight Molecular Diagnostic… | 38.76% | 12 684 884 | 2026-06-30 |
| STAAR Surgical Company | 32.12% | 16 123 842 | 2026-06-30 |
| Lineage Cell Therapeutics In… | 19.6% | 49 560 992 | 2026-06-30 |
advertisement
